Rod cGMP phosphodiesterase 6 (PDE6) is a key enzyme of the phototransduction cascade, consisting of PDE6α, PDE6β, and two regulatory PDE6γ subunits. PDE6 is membrane associated through isoprenyl membrane anchors attached to the C-termini of PDE6α and PDE6β and can form a complex with prenyl-binding protein δ (PrBP/δ), an isoprenyl-binding protein that is highly expressed in photoreceptors. The stoichiometry of PDE6-PrBP/δ binding and the mechanism by which the PDE6-PrBP/δ complex assembles have not been fully characterized, and the location of regulatory PDE6γ subunits within the protein assembly has not been elucidated. To clarify these questions, we have developed a rapid purification method for PDE6-PrBP/δ from bovine rod outer segments utilizing recombinant PrBP/δ. Transmission electron microscopy of negatively stained samples revealed the location of PrBP/δ and, thus, where the carboxyl-termini of PDE6α and PDE6β must be located. The threedimensional structure of the PDE6αβγ complex was determined up to 18 Å resolution from single-particle projections and was interpreted by model building to identify the probable location of isoprenylation, PDE6γ subunits, and catalytic sites.
Introduction
Rod cGMP phosphodiesterase 6 (PDE6) is a key effector enzyme in vertebrate visual signal transduction. PDE6 belongs to the phosphodiesterase (PDE) superfamily, whose members (PDE1-11) regulate the cellular concentrations of the second messengers cAMP and cyclic guanosine 3′,5′-monophosphate (cGMP).
1,2 PDEs exist as homodimeric or heterodimeric proteins that comprise a highly conserved C-terminal catalytic domain and a regulatory Nterminus, often consisting of an N-terminal GAF-A domain and an intermediate GAF-B domain. [1] [2] [3] [4] In contrast to other PDE family members, PDE6 utilizes an additional small regulatory protein and is thus made of three subunits-PDE6α (∼ 99 kDa), PDE6β (∼ 99 kDa), and PDE6γ (∼ 10 kDa)-that form a heterotetramer in a molar ratio of 1:1:2.
5-7 Although PDE6γ inhibits the catalytic domains of both PDE6α and PDE6β, 8, 9 PDEαβγ 2 still has basal cGMP hydrolytic activity. 6 Both catalytic subunits PDE6α and PDE6β carry a CAAX motif at their C-termini for posttranslational isoprenylation and carboxymethylation; PDE6α is farnesylated, whereas PDE6β is geranylgeranylated. 10 These modifications serve as membrane anchors for attachment of PDE6 to rod outer segment (ROS) membranes. 5, 10, 11 The 17-kDa prenyl-binding protein δ (PrBP/δ) [12] [13] [14] is able to extract PDE6 from ROS membranes by binding to the isoprenylated carboxyl-terminus of the catalytic subunits. 15 Using fluorescence resonance energy transfer techniques, Zhang et al. showed that PrBP/δ specifically binds geranylgeranyl and farnesyl moieties with a K d of 19 .06 μM and 0.70 μM, respectively. 13 PrBP/δ is evolutionarily highly conserved and expressed throughout the animal kingdom. The homology among bovine, human, and mouse PrBP/δ polypeptides is ∼99% and falls to 69% between Caenorhabditis elegans and humans. 16, 17 In mammals, PrBP/δ is primarily localized to the retina, but is also present in nonretinal tissues. 12 Deletion of PrBP/δ in mouse has profound effects on the trafficking of farnesylated GRK1 and PDE6 to the outer segments, 18 suggesting that PrBP/δ functions as a chaperone in the transport of a subset of prenylated proteins.
A wealth of structural information on PDEs exists; the recently determined nearly full-length structure of PDE2 provides the first structure of an intact PDE and insights into its regulation, domain arrangement, and function. 19 The structure of the cone GAF-A domain of chicken PDE6 has been solved. 20 NMR measurements indicate conformational change upon cGMP binding, and unfolding experiments revealed that that cGMP-free GAF-A is thermodynamically less stable than the cGMP-bound form. 20 Neither the structure of the PDE6α or PDE6β GAF-B domains nor their functional implications are known, but the structure of the catalytic domain of a PDE5/6 chimeric protein complexed with the inhibitory PDE6γ peptide has been elucidated, giving insight into the regulatory mechanism of PDE6γ. 21 A cocrystal of the transducin α subunit (G t α) complexed with the core of PDE6γ specifies the region of interaction between these entities. 22 Moreover, the crystal structure of PrBP/δ revealed that it has an immunoglobulin-like β-sandwich fold that forms a hydrophobic isoprenyl-binding pocket. 18 Finally, three-dimensional (3D) electron microscopy of negatively stained samples unveiled the overall architecture of PDE6 at 30 Å resolution. 23, 24 Herein we describe a novel method for purification of PDE6 in complex with PrBP/δ. We present the biochemical characterizations of both PDE6αβγ 2 and PDE6αβγ 2 -PrBP/δ. By comparing the projection structures of negatively stained PDE6αβγ 2 and PDE6αβγ 2 -PrBP/δ samples, we identified the PrBP/δ binding site/isoprenylation site. In addition, we present the 3D structure of the PDE6 complex at 18 Å resolution generated from single-particle images by weighted backprojection. 25 Model building has been performed to fully interpret this structure.
Results
Purification of PDE6 and PDE6-PrBP/δ PDE6 complexes were purified as described in Materials and Methods. PDE6 was extracted from ROS membranes with a hypotonic buffer and further purified by propyl-agarose affinity chromatography. Fractions containing PDE6 were pooled, concentrated, and subjected to gel-filtration chromatography using a Superdex 200 column (Fig. 1a) . PDE6-PrBP/δ-GST (PrBP/δ and GST fusion protein) was isolated by extraction of PDE6 from ROS membranes with recombinant PrBP/δ-GST and purified on a GSTrap column. This purification Fig. 1 . Purification of PDE6 and PDE6-PrBP/δ by fast protein liquid chromatography gel-filtration and functional analyses. (a) Propyl-agarose chromatographic purification of PDE6 released from ROS membranes. Peak fractions contain PDE6αβγ, G t αβγ, and G t βγ. Inset: PDE6 peak after gel filtration. (b) Elution profile of concentrated pooled PDE6-PrBP/δ-GST fractions after thrombin digestion. The peak fractions are PDE6-PrBP/δ, GST, and free (excess) PrBP/δ. PDE6-PrBP/δ fractions were collected and used for further biochemical, biophysical, and microscopic experiments. Inset: 12% SDS-PAGE separation of PDE6αβγ 2 -PrBP/δ. complexes exhibit an elongated shape with a wide top and a narrower end. Reproducible substructure is enhanced in the class averages shown in the inset, revealing two stain-filled cavities. (b) Similar particles are observed in micrographs of PDE6-PrBP/δ preparations. Upon closer inspection, ∼ 10% of these complexes show an additional domain protruding from the wider end (arrowheads). Even less frequently, two such domains are found to be attached. The selected class averages (inset) show that these protruding domains emerge from a well-defined site, which is the putative location of isoprenylation in the catalytic domain (see also Fig. S4 ). (c) PDE6-PrBP/δ-GST complexes are significantly longer as a result of the PrBP/δ-GST chimeric protein attached to the wider end (arrowhead). Class averages in the top row of the inset display PDE6-(PrBP/δ-GST) 2 complexes, whereas the bottom row shows PDE6-PrBP/δ-GST complexes. step allowed the separation of PDE6-PrBP/δ-GST from contaminating proteins (Fig. S1 ). Fractions containing PDE6-PrBP/δ-GST were pooled, digested with thrombin, and separated by gel filtration (Fig. 1b) . Gel-filtration profiles showed an effective separation of PDE6 from transducin subunits (G t in Fig. 1a) , an effective separation of PDE6-PrBP/δ from glutathione S-transferase (GST), and an excess of the PrBP/δ protein (Fig. 1b) . Purified PDE6 elutes from the gel-filtration column with an apparent molecular mass of 220 kDa, whereas PDE6-PrBP/δ elutes at 250 kDa.
Stoichiometry of purified PDE6 and PDE6-PrBP/δ Subunits of PDE6 and PDE6-PrBP/δ preparations were separated by SDS-PAGE, and the molar ratio for PDE6α/PDE6β/PDE6γ was confirmed to be 1:1:2 for PDE6, in agreement with published results, 7, 26 whereas the molar ratio for PDE6α/ PDE6β/PDE6γ/PrBP/δ was 1:1:2:2, in contrast to 1:1:2:1, as previously published.
12 Native electrophoresis, followed by immunoblotting, showed single bands of PDE6αβγ 2 and PrBP/δ-PDE6, respectively, suggesting that the heterooligomers formed stable complexes (data not shown).
Projection maps of PDE6, PDE6-PrBP/δ, and PDE6-PrBP/δ-GST Negatively stained PDE6 and PDE6-PrBP/δ preparations exhibit particles with a length of 132 ± 7 Å and a width of 100 ± 3 Å (Fig. 2a and b) . They have both a wide end and a narrow end, with the latter being identified previously as the N-terminus. 23 Upon initial observation, these particles appear identical. On closer inspection, a minor fraction (b10%) of the PDE6-PrBP/δ complexes showed an additional small domain protruding from the catalytic domains and an even smaller fraction of particles having two additional protruding domains (Fig. 2b, arrowheads) . These protrusions have a size that is compatible with the mass of PrBP/δ (∼ 17 kDa) and are most clearly discerned in b 10% of the class averages obtained by multivariate statistical analysis (Fig. 2b, inset) . A few class averages also showed the existence of two protrusions and document the presence of two binding sites for PrBP/δ. PDE6-PrBP/δ-GST complexes have a length of 175 ± 8 Å and roughly the same width as the PDE6 particles. Because GST (∼ 25 kDa) significantly increases the mass of protrusions attached to isoprenylation sites at the catalytic domains, the additional domain is well visible (Fig. 2c , arrowheads). The class averages shown in the top row of the inset exhibit a domain that corresponds to two δ-GST moieties, whereas the bottom row shows averages of PDE6 complexes that have a single PrBP/δ-GST construct attached. Visible connections to the catalytic domains are mostly only on one side-notably all of them linking the PrBP/δ-GST protein to the same location where PrBP/δ subunits are found (Fig. 2b, inset) . To further establish the location of PrBP/δ, we calculated 10 class averages of PDE6 and PDE6-PrBP/δ, the corresponding standard deviation (SD) maps, and, finally, the difference map PDE6-PrBP/δ-PDE6. As illustrated in Fig. 2d , most of the statistical fluctuations between PDE6 class averages occur at the periphery of the complex as a result of variations in negative stain depth (Fig. 2d2) . In spite of the disorder of PrBP/δ, two clear yet smeared out additional blobs are visible in the average from the 10 PDE6-PrBP/δ class averages in the inset to Fig. 2b (Fig. 2d3) . The corresponding SD map exhibits a strong signal at the putative location of PrBP/δ (Fig. 2d4) . Finally, the difference map (Fig. 2d5 ) reveals clear signals due to two PrBP/δs in addition to stain variations mainly at the periphery of the PDE6-PrBP/δ complex.
Three-dimensional structure of the PDE6 complex As illustrated in Fig. 2 and Fig. S2c , elongated particles tended to adsorb to carbon film in a preferential orientation. Therefore, we recorded additional images from both PDE6 and PDE6-PrBP/δ grid preparations, with the grid tilted at 45°. Because the population of complexes with one or two PrBP/δ proteins bound was b10% for the PDE6-PrBP/δ preparation, both data sets were merged to determine the 3D structure of PDE6. The complete data set comprising 14,180 singleparticle projections allowed us to calculate a 3D map using a simple model for bootstrapping the reconstruction and refinement procedure. The model selected comprised two Gaussian blobs with a diameter corresponding to the approximate mass of GAF-A, two blobs for GAF-B, and two larger blobs for the catalytic domains. The centers of these spherical objects were selected to match the shape of the most prominent class averages of particles acquired at 0°tilt. Because bovine PDE6α and PDE6β share a sequence homology of ∼ 91% and exhibit almost the same mass (98,331 Da versus 99,341 Da), and because the holoenzyme PDE6αβ is associated with two PDE6γ subunits, we imposed a 2-fold symmetry during the refinement process; calculation of maps without the 2-fold averaging results in poorer, noisy maps, which are also 2-fold symmetric. The 3D maps converged rapidly when this model was used: within a few cycles, the characteristic shape of the PDE6 complex we observed became visible, and a stable map was obtained within 15 cycles (Fig. S2a) . According to the 50% criterion, the Fourier shell correlation (FSC) function documents a resolution of 18 Å, with additional information above the theoretical 3σ level out to 13 Å (Fig. S2b) . Thus, the final 3D map was bandwidth limited to 13 Å.
The structure of the PDE6 complex roughly resembles a skull ( Figs. 3 and 4; Fig. S4 ) and shows considerably more detail than maps previously produced by essentially the same approach. 23, 24 Notably, the PDE6 complex appears to have two pronounced cavities, with the larger cavity being formed by the catalytic domains at its top and the GAF-B domains at its bottom. This C-terminal cavity is partially closed by an oblate 30-Å-wide and 15-Å-thick domain (Fig. 3, asterisk) that is linked to the GAF-B domain by a thin connector (Fig. 3 , arrowheads). The N-terminal cavity is more open and is closed off at its bottom by the GAF-A domains. Cross sections in the bottom row of Fig. 3 demonstrate that the catalytic domains are hemispherical, that the GAF-B domains exhibit a sheet-like density separating the upper and lower cavities, and that the GAF-A domains are connected by a narrow interface.
Modeling
To better understand our electron microscopy map, we used all the structural information available and constructed a chimeric structure from the GAF-A domain of PDE6C [Protein Data Bank (PDB) ID 3DBA], a homology model of the GAF-B domain and the PDE5/6 chimeric catalytic domain (PDB ID 3JWQ). Attempts to fit the structure of PDE2A (PDB ID 3IBJ) failed because this structure was ∼ 16 Å longer than the PDE6 map (Fig. S3) . Therefore, we began by fitting the GAF-A dimer into the lower lobe with minor disruption of the dimer present in the crystal structure. As there is no structure of a closely related homolog for the GAF-B domain, we utilized SWISS-MODEL 27 to build a homology model based on GAF-B from PDE2A and fitted it into the middle lobe of the map. The PDE5/6 catalytic domain has roughly the shape of a halfsphere, having the catalytic cleft on its rather flat surface and the last residue on the spherical surface. Our observation that PrBP/δ binds to the spherical side of the catalytic domain supports the placement of the catalytic domain into the half-sphere density, with the flat side facing the cavity. Therefore, the catalytic cleft 21 must open toward the interior of the upper cavity of PDE6, as marked with an arrow in Fig. 3 (bottom row). Finally, the connection between the GAF-B domain and the catalytic domain predicted to be mostly helical needed to accommodate ∼ 50 residues. These constraints were best satisfied with an entangled arrangement of the PDE6α and PDE6β subunits, assigning the thin connection between the GAF-B domain and the catalytic domain to a long connecting helix. After placing the domains into the map by employing the features of CHIMERA, we built connecting helices, and we refined the model using Coot. Once one entire monomer had been fitted, we generated the dimer by applying the 2-fold symmetry imposed on the map obtained by electron microscopy (Fig. 4) .
Discussion
In this study, we present the purification of free PDE6 and the complexes formed by PDE6 and PrBP/δ in the form of PDE6-PrBP/δ-GST and PDE6-PrBP/δ. We compare the biochemical properties of PDE6 and PDE6-PrBP/δ and elucidate their structure by electron microscopy and single-particle processing of negatively stained PDE6 samples.
Complex formation between PDE6 and PrBP/δ subunits
Previous isolation protocols for PDE6-PrBP/δ resulted in a complex containing one PrBP/δ per PDE6 oligomer, although the possibility of additional PrBP/δ subunits was not excluded. 12 Our attempts to reconstitute the PDE6-PrBP/δ complex in solution from PDE6 (purified on propyl-agarose resin after extraction under hypotonic conditions) and recombinant PrBP/δ by size-exclusion chromatography failed to yield a homogenous complex Fig. 3 . Three-dimensional structure of PDE6 at 18 Å resolution. The skull-like shape of the PDE6 complex houses two major cavities: one enclosed at the top by the catalytic domains (C) and an oblate 30-Å-wide density (*), and the other enclosed by the GAF-A domains at the bottom (GA). The oblate density is connected to the GAF-B domain (GB) by a slender linker (arrowheads). GAF-B forms a shelf-like structure separating the two cavities. Cut-away representations show the hemispherical shape of the catalytic domains. This shape was decisive in fitting the X-ray structure of the PDE5/6 chimeric protein into the map, resulting in the active site being located on the interior surface of the top cavity (arrow). The map was rendered at 100% mass, and each view is rotated 45°counterclockwise with respect to its left neighbor. Scale bar represents 50 Å.
with a well-defined ratio between PDE6 and PrBP/ δ. For that reason, we elected to purify the PDE6-PrBP/δ complex directly from ROS membranes, where binding of PDE6 and PrBP/δ occurs and where PDE6 is properly presented on the surface of the lipid bilayer. Stoichiometry estimates by Coomassie-blue-stained SDS-PAGE for the PrBP/δ subunits suggested that approximately two PrBP/ δs are bound per PDE6 oligomer, indicating that both isoprenyl anchors (farnesyl and geranylgeranyl) bind PrBP/δ. Since our primary goal was simply to identify the binding site of PrBP/δ, we did not attempt to determine the stoichiometry with a more quantitative method.
We emphasize that excess PrBP/δ-GST does not result in unspecific binding to PDE6. Firstly, gelfiltration chromatograms exhibit a symmetric sharp peak of PDE6-PrBP/δ, with complete separation from free unbound PrBP/δ subunits (Fig. 1b) . Secondly, single-particle projections document that PrBP/δ-GST always binds the catalytic domain where isoprenylation is located (Fig. 2c) . If PrBP/δ-GST proteins were to bind nonspecifically, evidence of this would be seen in the images of negatively stained complexes. All of our biochemical experiments and functional analyses (data not shown) revealed that, after purification, both PDE6 and PDE6-PrBP/δ are active and stable in biochemical assays. Moreover, we could detect no difference in catalytic efficiency, consistent with results published by other groups. 28 Differences between projections of PDE6 and PDE6-PrBP/δ complexes Recognizing a single 17-kDa protein within a roughly 220-kDa complex by negative-stain transmission electron microscopy is an ambitious goal. However, as a result of the preferential adsorption of PDE6 complexes with the long axis parallel with the carbon film and the peripheral location of the isoprenylation sites, the PrBP/δ protein could be seen as a protruding domain at the wider end of the PDE6 complex (Fig. 2b) . During sample transfer between two laboratories and negative staining procedure, a large fraction of the PDE6-PrBP/δ complexes dissociated. The low occupancy (b10% for a single protruding domain/PDE6; b2% for two protruding domains/PDE6) and the conformational variation in these protrusions suggested that they might not be identified by single-particle analysis. However, multivariate statistical classification and averaging of projections from negatively stained PDE6-PrBP/δ complexes reveal that 10% of the class averages had one protrusion-or even less frequently two protrusions-located at the periphery of the catalytic domains (Fig. 2b, inset) . Comparative analyses of the top-view class averages of both PDE6 and PDE6-PrBP/δ complexes showed variations in PDE6 projections mainly at their periphery, reflecting variations in stain thickness (Fig. 2d1 and  d2 ). For PDE6-PrBP/δ, the SD map (Fig. 2d4) exhibits maxima that correlate with the locations of PrBP/δ, which are distinct in the PDE6-PrBP/δ average (Fig. 2d3) . This signal and that of the staining variation are prominent in the difference map displayed in Fig. 2d5 . The location of PrBP/δ is confirmed by class averages of PDE6-PrBP/δ-GST complexes (Fig. 2c) . It is interesting to note that the class averages of PDE6-PrBP/δ-GST particles unveil more often only one connection (rather than two connections) to the catalytic domain even when two PrBP/δ-GSTs are bound (Fig. 2c, inset, top row) , possibly reflecting the difference between the affinity of PrBP/δ for geranylgeranyl moiety and the affinity of PrBP/δ for farnesyl moiety. 13 
Three-dimensional map of PDE6
We selected 14,180 single-particle projections from negatively stained PDE6 and PDE6-PrBP/δ preparations, with about 40% acquired from grids inclined at 45°with respect to the optical axis of the electron microscope. This helped to improve the coverage of the tilt angle space (Fig. S2) , a problem often found with particles adsorbed to the carbon film in a preferential orientation. We calculated 3D maps without enforcing the 2-fold symmetry expected from biochemical data to check for deviations from this symmetry. Such maps were noisier but clearly symmetric, and prompted us to implement the 2-fold symmetry constraint throughout the refinement. The final map shown in Fig. 3  comprised 11,481 projections, or 81% of all particles picked. All projections were corrected for effects of the contrast transfer function-an effort usually not invested for processing images of negatively stained samples. This and the large data pool helped to significantly improve the resolution compared to previous reports. 23, 24 The pertinent features of the PDE6 3D map are the overall skull-like shape and the upper and lower cavities. Starting from a crude model composed of six spherical densities, the open lower cavity and a rather enclosed upper cavity emerged after four refinement cycles, and the map converged after 15 cycles to where the FSC function indicated a resolution of 18 Å (Fig. S2b) . Densities partially closing the top cavity are not visible in the lower-resolution maps previously published 23, 24 and represent new features in the 3D map presented here.
The challenge was how to interpret this 18-Å-resolution map. We exploited the available structural information to the fullest extent, starting from the most complete structure of a PDE family member, that of PDE2A. 19 However, this structure, with a length of ∼150 Å, could not be accommodated into the skull-like PDE6 structure with a ∼130 Å length (Fig. S3) . Moreover, the dimer interface between the linear extended PDA2 monomers, which forms the center and extends over the entire length of the complex, is not compatible with the two distinct large cavities that we observe in PDE6. In contrast, the good fit of the GAF-A structure of PDE6C (PDB ID 3DBA) to the narrower end of our PDE6 map provided the basis for the beginning of model building and fitting. The information on the isoprenylation site (Fig. 2b and c) and the hemispherical shape of the density allocated to the catalytic domain gave the constraints with which to fit the structure of the PDE5/6 catalytic domain (PDB ID 3JWQ) into the top of the skull. Accordingly, the catalytic cleft formed by the H-loop and M-loops 21 was found to open into the upper, rather secluded, cavity. This result is of profound functional significance, as sequestration of the catalytic site from the bulk cytoplasm might have implications for the regulation of activity through access to substrate.
Because the GAF-B sequence of PDE6 exhibits a low sequence homology to any GAF structure available, we resorted to the GAF-B homology model built by SWISS-MODEL 27 based on the PDE2A GAF-B domain structure 29 and the 20% sequence homology to the corresponding PDE6 sequence. The GAF-B homology model fits rather well to the shelf-like shape of the density between the GAF-A domain and the catalytic domain, requiring a short helical connection to the GAF-A domain and providing the starting location of the long helical connection linking the GAF-B domain and the catalytic domain. The map and the necessity to incorporate a 50-residue-long helical segment gave sufficient constraints to adjust the position of the catalytic domain. Taking into account the ∼ 91% homology of the PDE6α and PDE6β subunits, we obtained the model of PDE6αβ by applying the 2-fold symmetry imposed for calculating the 18-Å map. This chimeric model is shown in Fig. 4 , which illustrates the entangled fold of PDE6αβ. An alternative fit would have exhibited a right-handed entanglement rather than the left-handed entanglement presented here, but the functional implications of both models would be similar.
It is important to note that PDE6 is the only PDE that comprises an additional regulatory subunit, the inhibitory PDE6γ. Therefore, PDE6 is expected to possess a structure distinctly different from the PDE2A dimer, whose active sites are buried in the dimeric interface. Here, cGMP binding to the GAF-B domain leads to a conformational change that disrupts the dimer interface between the catalytic domains, allowing the substrate to access the active site. 19 In contrast, PDE6 regulation is mediated by binding of G t α to PDE6γ, whereas the roles and mechanisms of PDE6 GAF domains in the regulation of the enzyme remain largely obscure. 30 Putative location of the inhibitory PDE6γ subunit A wealth of information on PDE6γ-PDE6αβ interactions has accumulated: the PDE6γ N-terminus (residues 16-30) has been reported to interact with GAF-A, the central domain (residues 24-46), to enhance the affinity of PDE6γ for PDE6αβ, and the inhibitory C-terminal domain (residues 73-87) to block the catalytic sites of PDE6γ-PDE6αβ. 5, 8, [31] [32] [33] [34] [35] [36] The recent structure of the PDE5/6 chimeric catalytic domain showed the inhibitory PDE6γ peptide (residues 70-87) binding to the H-M loops that form the entrance to the catalytic site, 21 thus confirming previous biochemical analyses. While the polycationic GAF-domain-interacting region of PDE6γ (residues 24-45) was reported to interact with transducin, 37 the structure of the C-terminal half (residues 50-87) that interacts with the G t α subunit has been solved. 22 Finally, most recent data demonstrate the importance of the interaction of G t α with the N-terminal half of PDE6γ for allowing catalysis to occur. 36 Thus, the emerging picture of PDE6γ is that of an elongated adaptable protein with a central domain that binds to GAF-B, a C-terminus that interacts with the catalytic domain, and an unstructured N-terminal extension that binds to GAF-A. 31 Our 18-Å map contains a distinct oblate 30-Å-wide density that does not result from any part of the model and cannot readily be explained by residues lacking in the X-ray structures or by the homology models used (denoted with an asterisk in Figs. 3 and 4 and indicated in red shades in Fig. S4 ). We interpret this density to represent part of the PDE6γ subunit because it is at a location that would allow the C-terminal extension to reach the catalytic cleft 21 and would allow the N-terminus to interact with the GAF-A domain. 31, 32 This density also would be accessible to G t α, which must bind to the central region of PDE6γ in order to dislodge the inhibitory C-terminal domain buried in the upper cavity of PDE6. It is not known whether the G t α-PDE6γ complex remains bound to PDE6, but it is conceivable that the density we interpret as the central region of PDE6γ would be displaced upon binding to G t α, thereby not only removing the inhibitory PDE6γ from the catalytic site but also improving access to the catalytic site.
A working model for PDE6 regulation
The model of PDE6 shown in Fig. 4 and Fig. S4 , together with the wealth of biochemical and structural information available, fosters our hypothesis on molecular events in the activation of PDE6. Upon initiating the visual signaling cascade by a photon, many G t α subunits are activated and released from transducin to relieve PDE6 inhibition. Our localization of PrBP/δ (in pale blue in Fig. S4 ) indicates how PDE6 is attached to the membrane. Because both G t α and PDE6 are anchored in the membrane, they are also optimally aligned for interaction. 28, 38 Previous biochemical and structural studies implicate the Cterminus of PDE6γ in directly binding residues surrounding the catalytic site. 21 Through its interaction with the central region of PDE6γ (in red in Fig.  S4 ), G t α is able to extract PDE6γ from the PDE6αβγ 2 heterotetramer and thus to displace the inhibitory Cterminal domain. This provides access to the previously blocked PDE6 catalytic cleft that faces the interior of the top enclosed cavity.
Materials and Methods
Expression and purification of PrBP/δ proteins PrBP/δ-GST plasmid in pGex-2T expression vector was used, and purification was performed as previously described. 13 The PrBP/δ protein was purified from an overnight digest of PrBP/δ-GST with biotinylated thrombin, followed by 30 min of incubation with streptavidin agarose to remove thrombin. PrBP/δ was then separated from GST by Superdex 200 10/300 gelfiltration chromatography.
Purification of PDE6
Bovine ROS membranes were prepared from 100 frozen retinas (W. L. Lawson Co., Lincoln, NE) under dim red light in accordance with the procedure of Papermaster, 39 and PDE6 was purified in accordance with the procedure described by Goc et al. 40 Fractions containing PDE6 were pooled and concentrated to 2-4 mg/ml with a 30,000 molecular weight cutoff Centricon (Millipore, Billerca, MA). SDS-PAGE analysis indicated that PDE6 was purified to homogeneity, and 100 bovine retinas typically yielded ∼ 1-2 mg of PDE6 by this methodology. All protein concentrations were assessed utilizing Bradford reagent. 41 Purification of PDE6-PrBP/δ ROS membranes were incubated with PrBP/δ-GST, for 30 min at room temperature, at a ratio of 10:1 mg of total protein and washed with 10 ml of isotonic buffer [20 mM Hepes (pH 7.5), 5 mM MgCl 2 , 1 mM DTT, and 100 mM NaCl], followed by centrifugation at 25,000g at 4°C for 30 min. This extraction was performed three times, and the combined supernatants were cleared of ROS membrane particles by an additional centrifugation at 25,000g at 4°C for 60 min, followed by overnight dialysis at 4°C against phosphate-buffered saline containing 1 mM DTT. This solution was applied at 5 ml/min onto a 5-ml GSTrap column and washed with 3 column volumes of equilibrating buffer. Bound proteins were eluted with 20 ml of 50 mM Tris-HCl (pH 8.0) containing 10 mM glutathione and 1 mM DTT. Fractions containing PDE6-PrBP/δ-GST were pooled; dialyzed at 4°C against 10 mM Hepes (pH 7.5) containing 2 mM MgCl 2 , 1 mM DTT, and 100 mM NaCl; and digested with thrombin. The sample was then concentrated in a 10,000 molecular weight cutoff Centricon (Millipore) to a final volume of 0.25 ml and separated by gel filtration. Fractions containing PDE6 were again pooled and concentrated to 2-4 mg/ml. PDE6 was purified to homogeneity, as assessed by SDS-PAGE and immunoblotting. The typical yield of PDE6-PrBP/δ was 0.4-0.6 mg per 100 retinas.
Chemicals and reagents
Trypsin treated with L-(tosylamido-2-phenyl) ethyl chloromethyl ketone, as well as soybean trypsin inhibitors, was purchased from Worthington (Lakewood, NJ). All chemicals used for SDS-PAGE and immunoblotting were of electrophoresis grade and obtained from Bio-Rad (Hercules, CA), except for 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium, which was obtained from Promega (Madison, WI). Biotinylated thrombin and streptavidin agarose were obtained from Novagen (Gibbstown, NJ). Other chemicals were of reagent grade and obtained from Sigma (St. Louis, MO). The anti-PDEβ subunit (PDE β ), the anti-PDE6γ subunit (PDE6 γ ), and anti-PrBP/δ polyclonal antibodies were purchased from Abcam, Inc. (Cambridge, MA.). Alkaline-phosphataseconjugated goat anti-rabbit IgG (Promega) was used as secondary antibody. Propyl-agarose resin was prepared by coupling propylamine to CNBr-activated agarose (Santa Cruz Biotechnology, Inc.). Superdex 200 and GSTrap columns were purchased from GE Healthcare Bio-Sciences (Piscataway, NJ).
Quantification of the stoichiometry of PDE6α, PDE6β, and PDE6γ subunits and PrBP/δ protein in purified PDE6 and PDE6-PrBP/δ Samples of PDE6 were separated by 12% SDS-PAGE and stained with Coomassie blue. Ratios between the PDE6β subunits, PDE6γ subunits, and PrBP/δ protein were scanned and then quantified by densitometric analysis in Image J ‡.
Electron microscopy
PDE6 samples were diluted as required in the above dialysis buffer and adsorbed for 1 min to glow-discharged 400-mesh carbon-coated grids. These were washed and negatively stained with 2% (wt/vol) uranyl acetate and imaged either with a CM 100 operated at 80 kV or with a CM 200 FEG transmission electron microscope operated at 200 kV (Philips, Eindhoven, Netherlands). Electron micrographs were recorded at a nominal magnification of 52,000× on Kodak So-263 film at 0°, as well as at a 45°t ilt. Micrographs were digitized on a Primescan D 7100 drum scanner (Heidelberger Druckmaschinen AG) at a pixel size corresponding to 3.3 Å or 3.7 Å, depending on the microscope used.
Image analysis
Image processing was achieved with the EMAN software package. 42 Particles were manually selected for single-particle 3D reconstruction using BOXER. CTFIT achieved the phase flip required for images of tilted samples acquired with the CM 200 FEG. Refine2d.py calculated class averages from data sets collected from PDE6, PDE6-PrBP/δ, and PDE6-PrBP/δ-GST samples. Class averages were compared and used to appropriately scale projections recorded with different microscopes. Class averages of the magnification-refined and CTFcorrected particle projections were then taken to produce an initial 3D map of PDE6. A rough model comprising 2 × 3 Gaussian blobs that correspond to the GAF-A, GAF-B, and C-terminal domains of the PDE6α subunit was used to assign initial Euler angles to the class averages from a data set comprising ∼ 8500 projections taken at 0°t ilt and ∼ 5700 projections taken at 45°tilt. The emerging maps were refined until they had converged and finally submitted to the EOTEST function provided by EMAN to compute the FSC function for determining the resolution of the map.
Model building
The model was built as described in the text. Briefly, homology models (GAF-A based on PDE6C structure, PDB ID 3DBA; GAF-B based on PDE2A structure, PDB ID 3LBJ; structure of PDE5/6 chimera, PDB ID 3JWQ) were fitted by hand as rigid bodies utilizing Coot. Where appropriate, connecting helices were built to connect the individual protein domains, utilizing the distantly related full-length PDE2A structure as guide.
